KIR2DL4 Antibody Blocking peptide
KIR2DL4 Antibody Blocking peptide
Product Specifications
Product Name Alternative
Killer cell immunoglobulin-like receptor 2DL4, CD158 antigen-like family member D, G9P, Killer cell inhibitory receptor 103AS, KIR-103AS, MHC class I NK cell receptor KIR103AS, CD158d, KIR2DL4, CD158D, KIR103AS
UniProt
Q99706
Field of Research
Immunology & Inflammation
Form
Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Notes
For research use only.
Applications Notes
Synthetic peptide
AA Sequence
The synthetic peptide sequence used to generate the antibody orb1928142 was selected from the C-term region of human KIR2DL4. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb1817848 100 µg
NaPi2b / SLC34A2 Reference Antibody (Lifastuzumab)
Sign In for Pricing
View Details